Field evaluation of PIMA point-of-care CD4 testing in Rakai, Uganda.
about
Acceptability and feasibility of point-of-care CD4 testing on HIV continuum of care in low and middle income countries: a systematic review.Performance evaluation of BD FACSPresto™ point of care CD4 analyzer to enumerate CD4 counts for monitoring HIV infected individuals in NigeriaField Evaluation of a Point-of-Care CD4 Analyzer for Monitoring HIV Patients in the Interior of the Amazon Region, Brazil.Access to CD4 Testing for Rural HIV Patients: Findings from a Cohort Study in ZimbabweUsing BD Vacutainer CD4 Stabilization Tubes for Absolute Cluster of Differentiation Type 4 Cell Count Measurement on BD FacsCount and Partec Cyflow Cytometers: A Method Comparison Study from Zimbabwe.Performance Evaluation of the Becton Dickinson FACSPresto™ Near-Patient CD4 Instrument in a Laboratory and Typical Field Clinic Setting in South Africa.Errors generated by a point-of-care CD4+ T-lymphocyte analyser: a retrospective observational study in nine countriesPerformance of point-of-care CD4 testing technologies in resource-constrained settings: a systematic review and meta-analysis.Performance of FACSPresto Point-of-Care Instrument for CD4-T Cell Enumeration in Human Immunodeficiency Virus (HIV)-Infected Patients Attending Care and Treatment Clinics in Belgium and Tanzania.Point-of-care diagnostics, a major opportunity for change in traditional diagnostic approaches: potential and limitations.CD4 results with a bias larger than hundred cells per microliter can have a significant impact on the clinical decision during treatment initiation of HIV patients.PIMA™ point-of-care testing for CD4 counts in predicting antiretroviral initiation in HIV-infected individuals in KwaZulu-Natal, Durban, South Africa.
P2860
Q27305670-AAA6ACB9-98BE-4317-A5DE-4BD0CB9DDC9EQ32112299-625CF14E-C1BB-4C25-B408-74E22D2F1FB8Q35533012-16728A33-4617-4E79-848E-75815FC8FC31Q35665866-A38AD6EB-9D52-4479-ABC3-D8F853599A71Q35752283-26230A2A-EC54-42B5-B096-FE198533CE59Q36029182-732E1DF0-6768-4450-B3FB-C8DA8620F5D5Q36089448-75309D95-4FCE-437F-81BD-5B3D5B3EDABEQ36171165-2253C793-FACD-44B6-A042-9BBE01D28192Q36262368-4656190F-2461-445E-9A16-399B26253F34Q38258595-7E98A338-C73B-4823-B3FA-0DF97555F3A8Q38961200-21562645-BC16-4396-B10C-661FD7FD2A2BQ53759790-6FE734A8-4807-4B6E-9B92-AB24A9D9F357
P2860
Field evaluation of PIMA point-of-care CD4 testing in Rakai, Uganda.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Field evaluation of PIMA point-of-care CD4 testing in Rakai, Uganda.
@ast
Field evaluation of PIMA point-of-care CD4 testing in Rakai, Uganda.
@en
type
label
Field evaluation of PIMA point-of-care CD4 testing in Rakai, Uganda.
@ast
Field evaluation of PIMA point-of-care CD4 testing in Rakai, Uganda.
@en
prefLabel
Field evaluation of PIMA point-of-care CD4 testing in Rakai, Uganda.
@ast
Field evaluation of PIMA point-of-care CD4 testing in Rakai, Uganda.
@en
P2093
P2860
P1433
P1476
Field evaluation of PIMA point-of-care CD4 testing in Rakai, Uganda.
@en
P2093
Jjingo Kasule
Larry W Chang
Lawrence Lubyayi
Martin Buwembo
Richard Musoke
Ronald M Galiwango
Sarah Kalibbala
Steven J Reynolds
P2860
P304
P356
10.1371/JOURNAL.PONE.0088928
P407
P577
2014-03-10T00:00:00Z